Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways
- PMID: 21801852
- DOI: 10.1016/j.bbalip.2011.07.009
Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways
Abstract
Bioactive N-acylethanolamines include anandamide (an endocannabinoid), N-palmitoylethanolamine (an anti-inflammatory), and N-oleoylethanolamine (an anorexic). In the brain, these molecules are formed from N-acylphosphatidylethanolamines (NAPEs) by a specific phospholipase D, called NAPE-PLD, or through NAPE-PLD-independent multi-step pathways, as illustrated in the current study employing NAPE-PLD-deficient mice. Although N-acylethanolamine plasmalogen (1-alkenyl-2-acyl-glycero-3-phospho(N-acyl)ethanolamine, pNAPE) is presumably a major class of N-acylethanolamine phospholipids in the brain, its enzymatic conversion to N-acylethanolamines is poorly understood. In the present study, we focused on the formation of N-acylethanolamines from pNAPEs. While recombinant NAPE-PLD catalyzed direct release of N-palmitoylethanolamine from N-palmitoylethanolamine plasmalogen, the same reaction occurred in the brain homogenate of NAPE-PLD-deficient mice, suggesting that this reaction occurs through both the NAPE-PLD-dependent and -independent pathways. Liquid chromatography-mass spectrometry revealed a remarkable accumulation of 1-alkenyl-2-hydroxy-glycero-3-phospho(N-acyl)ethanolamines (lyso pNAPEs) in the brain of NAPE-PLD-deficient mice. We also found that brain homogenate formed N-palmitoylethanolamine, N-oleoylethanolamine, and anandamide from their corresponding lyso pNAPEs by a Mg(2+)-dependent "lysophospholipase D". Moreover, the brain levels of alkenyl-type lysophosphatidic acids, the other products from lyso pNAPEs by lysophospholipase D, also increased in NAPE-PLD-deficient mice. Glycerophosphodiesterase GDE1 can hydrolyze glycerophospho-N-acylethanolamines to N-acylethanolamines in the brain. In addition, we discovered that recombinant GDE1 has a weak activity to generate N-palmitoylethanolamine from its corresponding lyso pNAPE, suggesting that this enzyme is at least in part responsible for the lysophospholipase D activity. These results strongly suggest that brain tissue N-acylethanolamines, including anandamide, can be formed from N-acylated plasmalogen through an NAPE-PLD-independent pathway as well as by their direct release via NAPE-PLD.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.Life Sci. 2005 Aug 19;77(14):1750-8. doi: 10.1016/j.lfs.2005.05.018. Life Sci. 2005. PMID: 15949819
-
New players in the fatty acyl ethanolamide metabolism.Pharmacol Res. 2014 Aug;86:1-10. doi: 10.1016/j.phrs.2014.04.001. Epub 2014 Apr 18. Pharmacol Res. 2014. PMID: 24747663 Review.
-
Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules.J Comp Neurol. 2008 Feb 1;506(4):604-15. doi: 10.1002/cne.21568. J Comp Neurol. 2008. PMID: 18067139
-
Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines.Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Dec;1862(12):1546-1561. doi: 10.1016/j.bbalip.2017.08.006. Epub 2017 Aug 24. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. PMID: 28843504 Review.
-
Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.Mol Biosyst. 2010 Aug;6(8):1411-8. doi: 10.1039/c000237b. Epub 2010 Apr 14. Mol Biosyst. 2010. PMID: 20393650 Free PMC article.
Cited by
-
Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex- and subtype-dependent observation.Neurogastroenterol Motil. 2021 Jan;33(1):e13961. doi: 10.1111/nmo.13961. Epub 2020 Aug 10. Neurogastroenterol Motil. 2021. PMID: 32779297 Free PMC article.
-
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6419-6426. doi: 10.1167/iovs.16-19437. Invest Ophthalmol Vis Sci. 2016. PMID: 27893106 Free PMC article.
-
An Introduction to the Endogenous Cannabinoid System.Biol Psychiatry. 2016 Apr 1;79(7):516-25. doi: 10.1016/j.biopsych.2015.07.028. Epub 2015 Oct 30. Biol Psychiatry. 2016. PMID: 26698193 Free PMC article. Review.
-
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.Front Endocrinol (Lausanne). 2021 Jul 7;12:720734. doi: 10.3389/fendo.2021.720734. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34305821 Free PMC article. Review.
-
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS.Int J Mol Sci. 2023 Oct 31;24(21):15829. doi: 10.3390/ijms242115829. Int J Mol Sci. 2023. PMID: 37958825 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases